Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Webb

Showing results (31-40 of 323) with videos related to

Pageof 33
Sort By:
Journal of the American Society of Nephrology : JASN|March 17, 2006
The endothelin system and its antagonism in chronic kidney diseaseNeeraj Dhaun, Jane Goddard, David J Webb
Lancet (London, England)|February 23, 2010
An endothelin antagonist for resistant hypertensionNeeraj Dhaun, Jane Goddard, David J Webb
British Journal of Clinical Pharmacology|October 24, 2002
A spoonful of sugar? Tomorrow's doctors 2002David J Webb, Simon R J Maxwell
Contributions to Nephrology|September 7, 2011
Endothelin antagonism in patients with nondiabetic chronic kidney diseaseNeeraj Dhaun, Jane Goddard, David J Webb
Lancet (London, England)|March 15, 2006
Clinical pharmacology--too young to die?Simon R J Maxwell, David J Webb
Lancet (London, England)|July 6, 2019
Improving medication safety: focus on prescribers and systemsSimon R J Maxwell, David J Webb
Frontiers in Endocrinology|November 20, 2012
Role of calcitonin gene-related peptide in cerebral vasospasm, and as a therapeutic approach to subarachnoid hemorrhageStelios Kokkoris, Peter Andrews, David J Webb
British Journal of Clinical Pharmacology|June 3, 2008
Internet pharmacy: a web of mistrust?Simon R J Maxwell, David J Webb
Nature Reviews. Cardiology|February 7, 2025
Novel pharmacological approaches to lowering blood pressure and managing hypertensionMatthew Sayer, David J Webb, Neeraj Dhaun
British Journal of Clinical Pharmacology|March 22, 2016
Implications of the BIA-102474-101 study for review of first-into-human clinical trialsMichael Eddleston, Adam F Cohen, David J Webb
Pageof 33

Showing results (31-40 of 323) with videos related to

Sort By:
Pageof 33
Journal of the American Society of Nephrology : JASN|March 17, 2006
The endothelin system and its antagonism in chronic kidney diseaseNeeraj Dhaun, Jane Goddard, David J Webb
Lancet (London, England)|February 23, 2010
An endothelin antagonist for resistant hypertensionNeeraj Dhaun, Jane Goddard, David J Webb
British Journal of Clinical Pharmacology|October 24, 2002
A spoonful of sugar? Tomorrow's doctors 2002David J Webb, Simon R J Maxwell
Contributions to Nephrology|September 7, 2011
Endothelin antagonism in patients with nondiabetic chronic kidney diseaseNeeraj Dhaun, Jane Goddard, David J Webb
Lancet (London, England)|March 15, 2006
Clinical pharmacology--too young to die?Simon R J Maxwell, David J Webb
Lancet (London, England)|July 6, 2019
Improving medication safety: focus on prescribers and systemsSimon R J Maxwell, David J Webb
Frontiers in Endocrinology|November 20, 2012
Role of calcitonin gene-related peptide in cerebral vasospasm, and as a therapeutic approach to subarachnoid hemorrhageStelios Kokkoris, Peter Andrews, David J Webb
British Journal of Clinical Pharmacology|June 3, 2008
Internet pharmacy: a web of mistrust?Simon R J Maxwell, David J Webb
Nature Reviews. Cardiology|February 7, 2025
Novel pharmacological approaches to lowering blood pressure and managing hypertensionMatthew Sayer, David J Webb, Neeraj Dhaun
British Journal of Clinical Pharmacology|March 22, 2016
Implications of the BIA-102474-101 study for review of first-into-human clinical trialsMichael Eddleston, Adam F Cohen, David J Webb
Pageof 33